Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Cancer Prev Res (Phila). 2015 Apr 23;8(7):650–656. doi: 10.1158/1940-6207.CAPR-15-0001-T

Figure 3.

Figure 3

Histopathology of intestinal tumor development associated with Blm/BLM in ApcMin/+ mice. A-F, Although BLM-Tg reduces adenoma numbers on the ApcMin/+ background, it does not alter the underlying histopathology of emerging adenomas: A, ApcMin/+ jejunum, boxed area highlights GIN; B, ApcMin/+;BLMT/T jejunum, boxed area highlights GIN; C, ApcMin/+;BLMT/T cecum, adenoma; D, ApcMin/+;BLM+/T colon, adenoma; E, ApcMin/+;BLM+/T jejunum, adenoma; F, ApcMin/+;BLMT/T ileum, adenoma. G-H, Blm haplo-insufficiency drives tumor development and accelerates the development of intestinal adenomas with high-grade dysplasia and invasive carcinoma: G, ApcMin/+;BlmCin/+, adenoma with high-grade dysplasia; H, ApcMin/+;BlmCin/+, invasive adenocarcinoma. All sections were stained with hematoxylin and eosin. Scale bars each represent 100 μm.